Press release
COVID-19 Saliva Screening Test Market Size & Growth 2024-2033 | Trends & Forecast
COVID-19 Saliva Screening Test Market Size
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16026&type=smp
According to The Business Research Company's, The COVID-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.57 billion in 2023 to $3.90 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the potential for home testing, unprecedented need for diagnostic testing, rise in public awareness, and research and development investment.
The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to integration with screening programs, regulatory support, growing demand for speedy, point-of-care COVID-19 tests, increasing population, and the rise of e-commerce. Major trends in the forecast period include increased adoption in non-healthcare settings, integration with digital health platforms, emergence of next-generation technologies, technological advancements, and strategic partnerships.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report
Market Drivers and Trends:
The increasing healthcare expenditure is expected to propel the growth of the COVID-19 saliva screening test potential market going forward. Healthcare expenditure is the entire amount spent on healthcare-related goods and services, including prescription drugs, hospital stays, doctor visits, medical equipment, and public health campaigns. The healthcare expenditure is increasing due to several factors, such as minimally invasive surgeries, cutting-edge diagnostic tools, increase in research and development for new drugs, utilization of healthcare services, and specialty medications. The higher healthcare expenditure can provide the necessary resources and support to leverage the full potential of COVID-19 saliva screening tests, contributing to more effective pandemic management and better public health outcomes. For instance, in May 2023, according to the Office for National Statistics, a UK-based statistics authority, the UK's healthcare expenditure grew by 9.7% in real terms and 9.4% in nominal terms. The overall amount spent on healthcare in the UK in 2021 was $367.25 billion (£280.7 billion), while the total amount spent on pharmaceuticals was $51.84 billion (£39.6 billion). Further, spending on preventative care more than quadrupled to $45.93 billion (£35.1 billion) in 2021 compared to the previous year. Therefore, the increasing healthcare expenditure is driving the growth of the COVID-19 saliva screening test potential market.
Major companies operating in the COVID-19 saliva screening test potential market are focused on developing innovative programs, such as COVID-19 saliva testing programs, to expand their product offerings and reach a broader customer base. A COVID-19 saliva testing program is an initiative or system implemented to test for SARS-CoV-2 (the virus that causes COVID-19) using saliva samples rather than more invasive nasopharyngeal or nasal swab samples. For instance, in April 2021, Mount Sinai Health System, a US-based healthcare network, launched the Mount Sinai COVID-19 PCR Saliva Testing program to provide quick, noninvasive, and precise testing. This testing program is designed to provide quick and accurate results, enabling individuals to return to in-person work settings and leisure activities confidently. The program's scalability is noteworthy, with plans to process up to 100,000 daily tests, ensuring widespread testing availability. Its success is further highlighted by the ability to report results within 24 hours for most tests, demonstrating efficiency and rapid response capabilities. The program aims to facilitate the safe return to in-person learning and activities by offering child-friendly and comfortable testing options. This initiative emphasizes the importance of testing in controlling the spread of COVID-19 and supports the community's well-being during the reopening phase.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.
COVID-19 Saliva Screening Test Potential Market 2024 Key Insights:
• The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%.
• The Role Of Increasing Healthcare Expenditure In Driving The Growth Of The COVID-19 Saliva Screening Test Market
• Innovative Technologies And Advanced Laboratory Techniques Driving Growth In The COVID-19 Saliva Screening Test Market
• North America was the largest region in the COVID-19 saliva screening test potential market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=16026&type=smp
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release COVID-19 Saliva Screening Test Market Size & Growth 2024-2033 | Trends & Forecast here
News-ID: 3709534 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Saliva
Impact of Rising Xerostomia Prevalence on the Artificial Saliva Market Emerges a …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Artificial Saliva Market Through 2025?
The market for artificial saliva has experienced swift expansion recently, projected to increase from $1.95 billion in 2024 to attain $2.21 billion by 2025, reflecting a compound annual growth rate (CAGR) of 13.1%; this historical upward trajectory…
Primary Catalyst Driving Artificial Saliva Market Evolution in 2025: Impact of R …
What market dynamics are playing a key role in accelerating the growth of the artificial saliva market?
The increasing incidence of dry mouth syndrome, also known as xerostomia, is projected to fuel the growth of the artificial saliva market. Xerostomia is marked by a continuous sense of dryness in the mouth. The upsurge in this condition has been largely due to the aging demographic, as well as the prevalent use of…
Artificial Saliva Market : An Overview
Introduction:
Artificial saliva is a synthetic product designed to mimic the natural saliva found in the human mouth. It is primarily used to alleviate symptoms associated with xerostomia, or dry mouth, a condition caused by reduced or absent saliva production. Xerostomia is often linked to medical conditions such as Sjögren's syndrome, radiation therapy for head and neck cancer, or side effects from certain medications. Artificial saliva products help to maintain oral…
Artificial Saliva Market
Artificial saliva is a synthetic product designed to replicate the functions of natural saliva in individuals who suffer from conditions that reduce saliva production. Dry mouth, also known as xerostomia, can result from various factors including aging, medication side effects, radiation therapy for cancer, or diseases like Sjögren's syndrome. Natural saliva plays a crucial role in maintaining oral health, aiding in digestion, and protecting the mouth from infections. When the…
Wearable devices to dominate the Artificial Saliva Market
The Artificial Saliva Market is likely to grow on a robust note in the next decade. The next decade would be seeing the integration of telehealth services with the physical ones that exist at the moment. Urgent care and primary care are bound to be accessed through virtual visits, along with improvement in collaboration with the clinics, dialysis centres, long-term care facilities, and mental health services. This shifting is to…
New HGH Saliva Antigen Covid Test gamechanger
An Austrian company HGH Disinfection und Cosmetique Gmbh, based in 9020 Klagenfurt created with a Korean partner a unique antigen salvia test unit which is so simple that anybody can use it. Till now mass testing was nasal stick by government and doctors. Now this new test unit can be used by everybody without a scarry stick in the nose and a result with 95% is ready in 10…
